Conservative treatment of ligamentous lumbar-pelvic pain

Authors: G. Istomin1, A. A. Kalyuzhka1, D. A. Istomin1, V. P. Kyryllov2, I. A. Zhuravska3, K. V. Dorohan1

1Kharkiv National Medical University. Ukraine
2MNE of the Kharkiv Regional Council «Regional Medical Sports Dispensary». Ukraine
3LLP «Doctor Alex», Kharkiv. Ukraine


An increased density of ligaments in the lumbopelvic region, that is typical for ligamentopathy, causes redistribution of the stress strain state of structures in the biomechanical system «lumbar spine – sacrum – sacroiliac joint – pelvis», thereby provoking development of degenerative-dystrophic changes. Proceeding from the above, the concept of conservative treatment for ligamentogenic lumbopelvic pain (LLPP) should provide restoration of the natural density of the ligament and use of structure modifying medicines. Objective: to develop a biomechanically and pathogenetically based technology for the conservative treatment of LLPP and assess of the efficacy of its use. Methods: 45 patients with LLPP were divided into three groups: I — extracorporeal shock-wave therapy, II — dietary supplement «Protecta», III — integrated treatment with dietary supplement «Protecta» in combination with shock-wave therapy.

The patients’ condition was assessed before the treatment, after 1 and 3 months following its finishing. Results: reduction of the pain and functional limitations was registered in patients from all the groups. Nevertheless the pain, stiffness and functional insufficiency decreased most significantly in cases from group III. Following 1 and 3 months after the end of their treatment course, these patients’ blood serum revealed lower values of destruction in their cartilaginous and osseous tissues as well as a reduced activity of marker enzymes. Biochemical marker values after 1 month following the end of their treatment course in patients from groups I and III were better versus group II, but after 3 months the dynamics of the examined indices were more expressed in groups II and III. Conclusion: the developed technology for conservative treatment of LLPP with use of extracorporeal shock-wave therapy and dietary supplement «Protecta» is effective, as it is confirmed by results of clinical and biochemical studies.

Key words: lumbopelvic pain, ligamentopathy, «Protecta», shock-wave therapy.

Published in the journal “Orthopedics, Traumatology and Prosthetics” №3 ‘2019

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design